alzres.com Report : Visit Site

Technical data of the alzres.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host alzres.com. Currently, hosted in United States and its service provider is Tiggee LLC .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Oscar Platform 201802052158-170 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

alzheimer's research & therapy | home page skip to content advertisement menu explore journals get published about bmc login my account search search all bmc articles search alzheimer's research & therapy menu home about articles submission guidelines search submit a manuscript wikimedia commons featured research article: circulating brain-enriched micrornas as novel biomarkers for detection and differentiation of neurodegenerative diseases "minimally invasive specific biomarkers of neurodegenerative diseases (nds) would facilitate patient selection and disease progression monitoring. we describe the assessment of circulating brain-enriched micrornas as potential biomarkers for alzheimer’s disease (ad)" articles recent most accessed content type: research | 23 june 2018 alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates authors: d. m. vargas, m. a. de bastiani, e. r. zimmer and f. klamt content type: research | 23 june 2018 vascular endothelial growth factor remains unchanged in cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia authors: ananya chakraborty, madhurima chatterjee, harry twaalfhoven, marta del campo milan, charlotte e. teunissen, philip scheltens, ruud d. fontijn, wiesje m. van der flier and helga e. de vries content type: viewpoint | 23 june 2018 infrequent false positive [ 18 f]flutemetamol pet signal is resolved by combined histological assessment of neuritic and diffuse plaques authors: milos d. ikonomovic, enrico r. fantoni, gill farrar and stephen salloway content type: viewpoint | 22 june 2018 why could meditation practice help promote mental health and well-being in aging? authors: gaël chételat, antoine lutz, eider arenaza-urquijo, fabienne collette, olga klimecki and natalie marchant content type: research | 19 june 2018 hepatitis b core vlp-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in tau.p301s mouse model of alzheimer’s disease and frontotemporal dementia authors: mei ji, xi-xiu xie, dong-qun liu, xiao-lin yu, yue zhang, ling-xiao zhang, shao-wei wang, ya-ru huang and rui-tian liu most recent articles rss view all articles content type: research | 15 march 2011 stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of app/ps1 transgenic mice authors: bin li, maria e gonzalez-toledo, chun-shu piao, allen gu, roger e kelley and li-ru zhao content type: review | 24 december 2014 bace1 inhibitor drugs in clinical trials for alzheimer’s disease authors: robert vassar content type: research | 3 july 2014 alzheimer’s disease drug-development pipeline: few candidates, frequent failures authors: jeffrey l cummings, travis morstorf and kate zhong content type: research | 1 august 2014 first-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an alzheimer’s disease model authors: eva kontsekova, norbert zilka, branislav kovacech, petr novak and michal novak content type: research | 26 august 2010 review of alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? authors: philippe robert, steven ferris, serge gauthier, ralf ihl, bengt winblad and frank tennigkeit most accessed articles rss view all articles resilience in dementia series brain resilience is the process of adapting well in the face of significant sources of stress, such as alzheimer’s disease pathology, other neurodegenerative conditions or biological aging. this thematic series provides a comprehensive overview of what factors contribute to brain resilience and how this affects brain health and cognitive function. read the articles guest ​​​​​​​editor: rik ossenkoppele aims and scope alzheimer's research & therapy is the major forum for translational research into alzheimer's disease. an international peer-reviewed journal, it publishes open access basic research with a translational focus, as well as clinical trials, research into drug discovery and development, and epidemiologic studies. the journal also provides reviews, viewpoints, commentaries, debates and reports. although the primary focus is alzheimer's disease, the scope encompasses translational research into other neurodegenerative diseases. alzheimer's disease international news adi 2018 is the longest running and most diverse international conference on dementia. the conference will feature leading experts on a range of topics including the latest in dementia science and care, presentations by people with dementia and their care partners, discussions on prevention, diagnosis, engaging minority groups and a unique focus on how technology and innovation is shaping the future. submit your abstract here by 31 january latest tweets alzheimer's blogs from bmc human cell models of alzheimer’s disease – moving beyond the familial 01 december 2017 rare variants of rab10 gene could be key in alzheimer’s disease resilience 29 november 2017 world alzheimer’s day 2017: earlier diagnosis is key to reduce impact of dementia 21 september 2017 advertisement submit a manuscript editorial board sign up for article alerts and news from this journal affiliated with alzheimer's research & therapy is affiliated with alzheimer's disease international (adi) , london, united kingdom. 2016 journal metrics speed 26 days from submission to first decision 25 days from acceptance to publication citation impact 6.154 - 2-year impact factor 5.664 - 5-year impact factor 1.309 - source normalized impact per paper (snip) 2.436 - scimago journal rank (sjr) usage 301,655 downloads 1456.5 usage factor social media impact 119 mentions more about our metrics advertisement alzheimer's research & therapy issn: 1758-9193 contact us submission enquiries: [email protected] general enquiries: [email protected] explore journals get published about bmc read more on our blogs receive bmc newsletters manage article alerts language editing for authors scientific editing for authors policies accessibility press center contact us leave feedback careers follow bmc bmc twitter page bmc facebook page bmc google plus page bmc weibo page by using this website, you agree to our terms and conditions , privacy statement and cookies policy. manage the cookies we use in the preference centre. © 2018 biomed central ltd unless otherwise stated. part of springer nature .